Literature DB >> 9611615

Evaluating the cost-effectiveness of clinical and public health measures.

J D Graham1, P S Corso, J M Morris, M Segui-Gomez, M C Weinstein.   

Abstract

Cost-effectiveness analysis, an analytic tool that expresses as a ratio the cost of obtaining an additional unit of health outcome, can help decision makers achieve more health protection for the same or less cost. We characterize the state of the cost-effectiveness analysis literature by reviewing how this technique is applied to various clinical and public health interventions. We describe the results of cost-effectiveness analyses for over 40 interventions to reduce cancer, heart disease, trauma, and infectious disease. The cost-effectiveness ratios for these interventions vary enormously, from interventions that save money to those that cost more than $1 million per year of life gained. The methods used to derive the cost-effectiveness ratios also vary considerably, and we summarize this variation within each health area. Greater uniformity of analytical practice will be necessary if cost-effectiveness analysis is to become a more influential tool in debates about resource allocation.

Entities:  

Mesh:

Year:  1998        PMID: 9611615     DOI: 10.1146/annurev.publhealth.19.1.125

Source DB:  PubMed          Journal:  Annu Rev Public Health        ISSN: 0163-7525            Impact factor:   21.981


  15 in total

Review 1.  AIDS policy modeling for the 21st century: an overview of key issues.

Authors:  M S Rauner; M L Brandeau
Journal:  Health Care Manag Sci       Date:  2001-09

2.  The economic cost of road traffic crashes in an urban setting.

Authors:  A García-Altés; K Pérez
Journal:  Inj Prev       Date:  2007-02       Impact factor: 2.399

Review 3.  Model-based evaluation of diabetic foot prevention strategies in Austria.

Authors:  Marion S Rauner; Kurt Heidenberger; Eva-Maria Pesendorfer
Journal:  Health Care Manag Sci       Date:  2005-11

4.  Cost-effectiveness league tables: valuable guidance for decision makers?

Authors:  Josephine Mauskopf; Frans Rutten; Warren Schonfeld
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

5.  Revisiting Wilson and Jungner in the genomic age: a review of screening criteria over the past 40 years.

Authors:  Anne Andermann; Ingeborg Blancquaert; Sylvie Beauchamp; Véronique Déry
Journal:  Bull World Health Organ       Date:  2008-04       Impact factor: 9.408

6.  Cost savings associated with 10 years of road safety policies in Catalonia, Spain.

Authors:  Anna García-Altés; Josep M Suelves; Eneko Barbería
Journal:  Bull World Health Organ       Date:  2012-12-07       Impact factor: 9.408

7.  Cost effectiveness of treating low HDL-cholesterol in the primary prevention of coronary heart disease.

Authors:  Joel W Hay; Kimberly L Sterling
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

8.  Promoting mental health recovery after hurricanes Katrina and Rita: what can be done at what cost.

Authors:  Michael Schoenbaum; Brittany Butler; Sheryl Kataoka; Grayson Norquist; Benjamin Springgate; Greer Sullivan; Naihua Duan; Ronald C Kessler; Kenneth Wells
Journal:  Arch Gen Psychiatry       Date:  2009-08

9.  HIV screening in the health care setting: status, barriers, and potential solutions.

Authors:  Stacey A Rizza; Robin J MacGowan; David W Purcell; Bernard M Branson; Zelalem Temesgen
Journal:  Mayo Clin Proc       Date:  2012-09       Impact factor: 7.616

10.  Impact of housing on the survival of persons with AIDS.

Authors:  Sandra K Schwarcz; Ling C Hsu; Eric Vittinghoff; Annie Vu; Joshua D Bamberger; Mitchell H Katz
Journal:  BMC Public Health       Date:  2009-07-07       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.